← Back to Patent Explorer
US4256726A Expired / Lapsed US ⏱️ 0.0 years remaining

99m Tc-Labeled radioactive diagnostic agent, and non-radioactive carrier therefor

Assignee: Nihon Medi Physics Co Ltd
•
Filing: 1978-05-01
•
Granted: 1981-03-17
•
Expires: 1998-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A 99mTc-labeled radioactive diagnostic agent, prepared by contacting 99mTc in the form of a pertechnetate with a non-radioactive carrier comprising pyridoxal or salt thereof, a stannous salt and an alpha -amino acid not having any hydrophilic functional group dissolved in an aqueous medium. This diagnostic agent is suitable for the examination of hepatobiliary ducts due to its smooth transfer through the hepatobiliary ducts as well as its high stability and non-toxicity.

Inventors

  • 👤 Makoto Kato
  • 👤 Masaaki Hazue

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 04:13
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/0404; A61K51/0406; A61K51/041; A61K51/044; A61K51/0455; A61K2123/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 27 words
A non-radioactive carrier comprising pyridoxal or a salt thereof, a stannous salt and an α-amino acid not having any hydrophilic functional group dissolved in an aqueous medium.
Claim 2
Dependent Claim 27 words
A non-radioactive carrier comprising pyridoxal or a salt thereof, a stannous salt and an α-amino acid not having any hydrophilic functional group dissolved in an aqueous medium.
Claim 3
Dependent Claim 21 words
The non-radioactive carrier according to claim 1, wherein the concentration of pyridoxal or its salt is not less than 20 mmol/liter.
Claim 4
Dependent Claim 25 words
The non-radioactive carrier according to claim 1, wherein the molar ratio of pyridoxal or its salt and the α-amino acid is from 0.3 to 3.
Claim 5
Dependent Claim 29 words
The non-radioactive carrier according to claim 1, wherein the stannous salt is used in an amount of 0.001 to 1 mol per 1 mol of pyridoxal or its salt.
Claim 6
Dependent Claim 44 words
A 99m Tc-labeled radioactive diagnostic agent which comprises 99m Tc in the form of a pertechnetate and a non-radioactive carrier comprising pyridoxal or a salt thereof, a stannous salt and an α-amino acid not having any hydrophilic functional group dissolved in an aqueous medium.
Claim 7
Dependent Claim 44 words
A 99m Tc-labeled radioactive diagnostic agent which comprises 99m Tc in the form of a pertechnetate and a non-radioactive carrier comprising pyridoxal or a salt thereof, a stannous salt and an α-amino acid not having any hydrophilic functional group dissolved in an aqueous medium.
Claim 8
Dependent Claim 78 words
The 99m Tc-labeled radioactive diagnostic agent according to claim 5, prepared by contacting an aqueous solution containing 99m Tc, the radioactivity of which is 0.1 to 50 mCi in a volume of 0.5 to 5 ml of aqueous solution at the time of administration, in the form of a pertechnetate with a non-radioactive carrier comprising pyridoxal or a salt thereof, a stannous salt and an α-amino acid not having any hydrophilic functional group dissolved in an aqueous medium.

References Cited (Backward Citations)

US3981980A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-16 1984-09-15 1985-03-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-16 1988-09-15 1989-03-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-16 1992-09-15 1993-03-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag